Marcus Bahra

8.0k total citations
209 papers, 4.8k citations indexed

About

Marcus Bahra is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Marcus Bahra has authored 209 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Surgery, 107 papers in Oncology and 68 papers in Hepatology. Recurrent topics in Marcus Bahra's work include Pancreatic and Hepatic Oncology Research (93 papers), Pancreatitis Pathology and Treatment (37 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers). Marcus Bahra is often cited by papers focused on Pancreatic and Hepatic Oncology Research (93 papers), Pancreatitis Pathology and Treatment (37 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers). Marcus Bahra collaborates with scholars based in Germany, United States and Switzerland. Marcus Bahra's co-authors include P. Neuhaus, Ulf P. Neumann, Jan M. Langrehr, R. Neuhaus, Gero Puhl, Thomas Berg, P. Neuhaus, Johann Pratschke, Dietmar Jacob and Daniel Seehofer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Marcus Bahra

203 papers receiving 4.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Marcus Bahra 2.1k 1.7k 1.7k 1.6k 927 209 4.8k
Shigeru Marubashi 2.1k 1.0× 2.0k 1.2× 2.6k 1.5× 1.1k 0.7× 1.3k 1.4× 269 6.0k
Yutaka Takeda 2.0k 1.0× 1.3k 0.8× 2.0k 1.2× 857 0.5× 1.3k 1.4× 311 5.3k
Albert Chan 1.3k 0.6× 3.6k 2.1× 2.2k 1.3× 2.1k 1.3× 913 1.0× 239 5.3k
Alyssa M. Krasinskas 2.6k 1.2× 548 0.3× 2.9k 1.7× 1.8k 1.1× 1.7k 1.8× 170 6.3k
Ksh Chok 1.3k 0.6× 4.0k 2.3× 2.5k 1.5× 2.1k 1.3× 1.1k 1.1× 222 5.8k
Tan To Cheung 1.6k 0.8× 4.3k 2.5× 2.3k 1.3× 2.3k 1.4× 1.2k 1.3× 252 6.8k
Kuniya Tanaka 2.8k 1.3× 2.8k 1.6× 2.7k 1.6× 701 0.4× 1.5k 1.6× 273 5.9k
Jean Saric 3.3k 1.5× 2.8k 1.6× 3.3k 1.9× 1.4k 0.9× 1.1k 1.2× 102 6.9k
Tu Vinh Luong 1.0k 0.5× 1.4k 0.8× 1.1k 0.6× 1.8k 1.1× 208 0.2× 113 3.9k
Shinji Togo 1.7k 0.8× 1.7k 1.0× 2.0k 1.2× 831 0.5× 1.1k 1.2× 167 3.9k

Countries citing papers authored by Marcus Bahra

Since Specialization
Citations

This map shows the geographic impact of Marcus Bahra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Bahra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Bahra more than expected).

Fields of papers citing papers by Marcus Bahra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Bahra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Bahra. The network helps show where Marcus Bahra may publish in the future.

Co-authorship network of co-authors of Marcus Bahra

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Bahra. A scholar is included among the top collaborators of Marcus Bahra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Bahra. Marcus Bahra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pelzer, Uwe, F Schneider, Anna Luisa Kühn, et al.. (2025). Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids. Cancer Cell International. 25(1). 321–321.
3.
Hilfenhaus, Georg, Martina Welzel, Catarina Alisa Kunze, et al.. (2024). Placental growth factor promotes neural invasion and predicts disease prognosis in resectable pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 153–153. 9 indexed citations
4.
Bahra, Marcus, et al.. (2023). Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC). Cancers. 15(3). 774–774. 4 indexed citations
5.
Nickel, Felix, Marius Distler, Karl‐Friedrich Kowalewski, et al.. (2023). Initial learning curves of laparoscopic and robotic distal pancreatectomy compared with open distal pancreatectomy: multicentre analysis. British journal of surgery. 110(9). 1063–1067. 7 indexed citations
6.
Roehle, Robert, Uwe Pelzer, Marcus Bahra, et al.. (2019). Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma. European Journal of Radiology. 119. 108626–108626. 5 indexed citations
7.
Globke, Brigitta, Fritz Klein, Uli Fehrenbach, et al.. (2019). Postoperative acute necrotizing pancreatitis of the pancreatic remnant (POANP): a new definition of severe pancreatitis following pancreaticoduodenectomy. HPB. 22(3). 445–451. 19 indexed citations
8.
Muckenhuber, Alexander, Anne Berger, Anna Melissa Schlitter, et al.. (2017). Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response. Clinical Cancer Research. 24(2). 351–359. 61 indexed citations
9.
Sinn, M., Jan Budczies, Frédérik Damm, et al.. (2017). TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study. Annals of Oncology. 28. v251–v251. 3 indexed citations
10.
Schoening, Wenzel, Andreas Y. Andreou, Marcus Bahra, et al.. (2016). Gender Matches in Liver Transplant Allocation: Matched and Mismatched Male-Female Donor-Recipient Combinations; Long-term Follow-up of More Than 2000 Patients at a Single Center.. PubMed. 14(2). 184–90. 16 indexed citations
11.
Andreou, Andréas, Marcus Bahra, Benjamin Struecker, et al.. (2015). Tumor DNA Index and α-Fetoprotein Level Define Outcome following Liver Transplantation for Advanced Hepatocellular Carcinoma. European Surgical Research. 55(4). 302–318. 1 indexed citations
12.
Detjen, Katharina, Georg Hilfenhaus, Martina Welzel, et al.. (2014). Axon Guidance Factor SLIT2 Inhibits Neural Invasion and Metastasis in Pancreatic Cancer. Cancer Research. 74(5). 1529–1540. 94 indexed citations
13.
Andreou, Andréas, Andreas Pascher, Wenzel Schöning, et al.. (2014). Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma. HPB. 17(2). 168–175. 17 indexed citations
14.
Sinn, M., Jana K. Striefler, Judith Lindner, et al.. (2014). SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study. Annals of Oncology. 25(5). 1025–1032. 63 indexed citations
16.
Grieser, Christian, Lars Stelter, Ingo G. Steffen, et al.. (2012). Morphological Analysis and Differentiation of Benign Cystic Neoplasms of the Pancreas Using Computed Tomography and Magnetic Resonance Imaging. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 185(3). 219–227. 5 indexed citations
17.
Kamphues, Carsten, Daniel Wittschieber, Frederick Klauschen, et al.. (2012). Prolyl Hydroxylase Domain 2 Protein Is a Strong Prognostic Marker in Human Gastric Cancer. Pathobiology. 79(1). 11–17. 11 indexed citations
18.
Riener, Marc‐Oliver, Frank Stenner, Heike Liewen, et al.. (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas #. Hepatology. 49(5). 1602–1609. 108 indexed citations
19.
Langrehr, Jan M., Marcus Bahra, Glen Kristiansen, et al.. (2007). Neuroendocrine tumor of the pancreas and bilateral adrenal pheochromocytomas. A rare manifestation of von Hippel–Lindau disease in childhood. Journal of Pediatric Surgery. 42(7). 1291–1294. 16 indexed citations
20.
Neumann, Ulf P., Thomas Berg, Marcus Bahra, et al.. (2004). Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation. 77(2). 226–231. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026